Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 49 of 114

  1. I3Y-MC-JPEF

    Eli Lilly Co.

    Breast Neoplasm, Neoplasm Metastasis

    phase 3 small molecule active

    1 trial

  2. I4V-MC-JAHU

    Eli Lilly Co.

    Systemic Juvenile Idiopathic Arthritis

    phase 3 small molecule active

    1 trial

  3. I4V-MC-JAHW

    Eli Lilly Co.

    Uveitis

    phase 3 small molecule active

    1 trial

  4. I4V-MC-JAHX

    Eli Lilly Co.

    Juvenile Idiopathic Arthritis

    phase 3 small molecule active

    1 trial

  5. I4V-MC-JAIP

    Eli Lilly Co.

    Atopic Dermatitis

    phase 3 small molecule active

    1 trial

  6. I4V-MC-JAJJ

    Eli Lilly Co.

    Diabetes Mellitus, Type 1

    phase 3 small molecule active

    1 trial

  7. I5T-MC-AACO

    Eli Lilly Co.

    Alzheimer Disease Dementia Brain Diseases Central Nervous System Diseases Nervous System Diseases Tauopathies Neurodegenerative Diseases Neurocognitive Disorders Mental Disorders

    phase 3 small molecule active

    1 trial

  8. I6T-MC-AMAX

    Eli Lilly Co.

    Crohn’s Disease

    phase 3 small molecule active

    1 trial

  9. I6T-MC-AMAY

    Eli Lilly Co.

    Crohn's Disease

    phase 3 small molecule active

    1 trial

  10. I6T-MC-AMBA

    Eli Lilly Co.

    Moderately to Severely Active Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  11. I6T-MC-AMCD

    Eli Lilly Co.

    Obesity or Overweight, Ulcerative Colitis

    phase 3 small molecule active

    1 trial

  12. I6T-MC-AMCE

    Eli Lilly Co.

    Obesity or Overweight, Crohn’s Disease

    phase 3 small molecule active

    1 trial

  13. I8F-MC-GPGN

    Eli Lilly Co.

    Type 2 Diabetes Mellitus

    phase 3 small molecule active

    1 trial

  14. I8F-MC-GPHP

    Eli Lilly Co.

    Obesity, Overweight

    phase 3 small molecule active

    1 trial

  15. I8F-MC-GPIX

    Eli Lilly Co.

    Obesity

    phase 3 small molecule active

    1 trial

  16. IAC regimen

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 small molecule completed

    1 trial

  17. IAE0972+ Methotrexate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NPC

    phase 3 mab active

    1 trial

  18. IB2017-04

    The George Institute

    Resectable, non-metastatic soft-tissue sarcoma (STS)

    phase 3 small molecule active

    1 trial

  19. IBCSG 59-19

    Partner Therapeutics Limited

    Female or male patients with histologically confirmed HR-positive, HER2-negative resected isolated locoregional recurrence (ILRR) of breast cancer.

    phase 3 small molecule active

    1 trial

  20. IBI363

    Takeda

    iO Resistant sqNSCLC

    phase 3 small molecule active

    1 trial

  21. IC 2021-07

    The George Institute

    Anaesthesia during free flap reconstruction surgery of the breast.

    phase 3 other active

    1 trial

  22. IC/LV/ACZ/PCHC

    The George Institute

    Chronic liver disease

    phase 3 small molecule active

    1 trial

  23. IC51

    Valneva Austria GmbH

    Encephalitis

    phase 3 mab completed

    1 trial

  24. ICM ADX-2191 injection

    Aldeyra Therapeutics

    Primary Vitreoretinal Lymphoma

    phase 3 small molecule active

    1 trial

  25. ICT-107

    Chongqing Precision Biotech Co., Ltd

    Glioblastoma Multiforme

    phase 3 mab completed

    2 trials

  26. ICY-AKC-301

    Dompe' Farmaceutici S.p.A.

    Atopic Keratoconjunctivitis

    phase 3 small molecule active

    1 trial

  27. ID-076A301

    Viatris Pharmaceuticals Co.,

    Acute myocardial infarction (AMI)

    phase 3 small molecule active

    1 trial

  28. IDE196

    IDEAYA Biosciences

    Metastatic Uveal Melanoma

    phase 3 small molecule active

    2 trials

  29. IDE196 (LXS196), IDE196 (LXS196)

    IDEAYA Biosciences

    Uveal Melanoma

    phase 3 small molecule active

    1 trial

  30. IDE196-002

    IDEAYA Biosciences

    HLA-A2 negative metastatic uveal melanoma

    phase 3 small molecule active

    1 trial

  31. IDE196-002

    IDEAYA Biosciences

    HLA-A2 negative metastatic uveal melanoma

    phase 3 small molecule active

    1 trial

  32. IEDAT-04-2022

    Quince Therapeutics

    Ataxia Telangiectasia

    phase 3 small molecule active

    1 trial

  33. IFCT-1701

    CERO THERAPEUTICS HOLDINGS, INC.

    Non small cell lung cancer

    phase 3 small molecule active

    1 trial

  34. IFCT-1805

    CERO THERAPEUTICS HOLDINGS, INC.

    Non Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  35. IFCT-2103

    CERO THERAPEUTICS HOLDINGS, INC.

    Non small cell lung cancer

    phase 3 small molecule active

    1 trial

  36. IFOM-CPT0092022PO008

    Fondazione Telethon ETS

    Colon cancer

    phase 3 small molecule active

    1 trial

  37. IFX-1-P3.4

    InflaRx GmbH

    ulcerative pyoderma gangrenosum

    phase 3 small molecule active

    1 trial

  38. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Advanced Or Metastatic Merkel Cell Carcinoma

    phase 3 small molecule active

    2 trials

  39. IGI, 10%

    Takeda

    Multiple Myeloma

    phase 3 mab active

    1 trial

  40. IGSC 20% infusion

    Takeda

    Primary Immunodeficiency Disease

    phase 3 mab completed

    1 trial

  41. IIBSP-IPV-2024-178

    The George Institute

    lumbar arthrodesis

    phase 3 small molecule active

    1 trial

  42. IIBSP-OXI-2017-18

    The George Institute

    ILD

    phase 3 small molecule active

    1 trial

  43. IIBSP-PRE-2024-198

    The George Institute

    intrauterine growth restriction, preeclampsia

    phase 3 small molecule active

    1 trial

  44. IIBSP-SAV-2025-178

    The George Institute

    Acute ischemic stroke

    phase 3 small molecule active

    1 trial

  45. IJB-SHAPERS-ODN-013

    The George Institute

    locally advanced rectal cancer

    phase 3 small molecule active

    1 trial

  46. IKT-001

    Inhibikase Therapeutics

    Pulmonary Arterial Hypertension

    phase 3 small molecule active

    1 trial

  47. IKT-001-201

    Inhibikase Therapeutics

    Pulmonary Arterial Hypertension

    phase 3 small molecule active

    1 trial

  48. IL-1Ra

    United Therapeutics Europe Ltd

    Subarachnoid Hemorrhage

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.